MelliCell, Inc. Employee Directory

Biotechnology ResearchMassachusetts, United States2-10 Employees

MelliCell, Inc. is a Newton, Massachusetts-based biotechnology research company focused on developing therapeutics for chronic and rare diseases by modeling weight gain in human fat cells in vitro. The firm converts human stem cells into fat cells and accelerates their growth to sizes thousands of times larger than conventional limits, creating models that reflect disease-relevant characteristics observed in patients. This approach supports the discovery of therapeutic targets and drugs that act on adipocyte-intrinsic mechanisms, potentially addressing limitations of existing treatments. Operating with a small team, the company sits in the biotechnology research sector and emphasizes mechanism-based discovery over traditional approaches. By linking fat cell size dynamics to disease progression, MelliCell aims to illuminate the role of adipocytes in chronic illness beyond obesity alone.\n\nTarget customers include pharmaceutical and academic researchers seeking new interventions for obesity-related and other chronic diseases tied to fat cell dysfunction. By focusing on adipocyte-intrinsic pathways, the company differentiates its approach from existing metabolic therapies, with the aim of complementing or extending current treatment options. In February 2024, MelliCell announced the addition of Dr. Fatima Cody Stanford to its advisory board, reflecting ongoing collaboration as it advances its research program.

Sign up for free to view info

Company overview Email format